| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99291 |
Critical care, evaluation and management of the critically ill patient, first 30-74 minutes |
14,346 |
3,049 |
$1.39M |
| 99233 |
Prolong inpt eval add15 m |
20,403 |
5,283 |
$785K |
| 99215 |
Prolong outpt/office vis |
11,287 |
11,091 |
$603K |
| 99232 |
Subsequent hospital care, per day, moderate complexity |
13,191 |
1,797 |
$430K |
| 95810 |
Polysomnography; sleep staging with 4 or more additional parameters |
750 |
740 |
$256K |
| 99223 |
Prolong inpt eval add15 m |
3,101 |
2,955 |
$199K |
| 95811 |
|
452 |
445 |
$161K |
| 99205 |
Prolong outpt/office vis |
1,817 |
1,811 |
$137K |
| 94729 |
|
3,171 |
3,160 |
$131K |
| 94060 |
|
3,168 |
3,157 |
$123K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
1,771 |
1,765 |
$108K |
| 99231 |
Subsequent hospital care, per day, straightforward or low complexity |
5,949 |
338 |
$105K |
| 94727 |
|
3,170 |
3,159 |
$102K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
3,622 |
3,570 |
$70K |
| 94760 |
|
2,876 |
2,865 |
$14K |
| 95831 |
|
966 |
958 |
$13K |
| 99292 |
|
96 |
67 |
$5K |
| 94375 |
|
332 |
331 |
$3K |
| 94200 |
|
328 |
327 |
$2K |
| 90674 |
|
24 |
24 |
$646.99 |
| 90756 |
|
21 |
21 |
$498.60 |
| 94618 |
|
12 |
12 |
$257.87 |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
41 |
41 |
$176.80 |
| G9695 |
Long-acting inhaled bronchodilator prescribed |
308 |
306 |
$0.01 |
| G8427 |
Eligible clinician attests to documenting in the medical record they obtained, updated, or reviewed the patient's current medications |
636 |
634 |
$0.01 |
| 3023F |
|
859 |
857 |
$0.01 |
| 1123F |
|
525 |
525 |
$0.00 |
| 1036F |
|
1,569 |
1,559 |
$0.00 |
| G8754 |
Most recent diastolic blood pressure < 90 mmhg |
162 |
162 |
$0.00 |
| G8839 |
Sleep apnea symptoms assessed, including presence or absence of snoring and daytime sleepiness |
509 |
499 |
$0.00 |
| G8420 |
Bmi is documented within normal parameters and no follow-up plan is required |
26 |
26 |
$0.00 |
| G8950 |
Elevated or hypertensive blood pressure reading documented, and the indicated follow-up is documented |
135 |
135 |
$0.00 |
| G9903 |
Patient screened for tobacco use and identified as a tobacco non-user |
13 |
13 |
$0.00 |
| G9906 |
Patient identified as a tobacco user received tobacco cessation intervention during the measurement period or in the six months prior to the measurement period (counseling and/or pharmacotherapy) |
13 |
13 |
$0.00 |
| 4040F |
|
417 |
417 |
$0.00 |
| 1090F |
|
308 |
308 |
$0.00 |
| G8842 |
Apnea hypopnea index (ahi), respiratory disturbance index (rdi) or respiratory event index (rei) documented or measured within 2 months after initial evaluation for suspected obstructive sleep apnea |
507 |
497 |
$0.00 |
| G8417 |
Bmi is documented above normal parameters and a follow-up plan is documented |
245 |
243 |
$0.00 |
| 4004F |
|
48 |
48 |
$0.00 |
| G8752 |
Most recent systolic blood pressure < 140 mmhg |
162 |
162 |
$0.00 |
| G8783 |
Normal blood pressure reading documented, follow-up not required |
49 |
49 |
$0.00 |